{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T21:24:11Z","timestamp":1785533051899,"version":"3.56.0"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,1]]},"DOI":"10.1093\/ajcp\/aqy121","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T21:37:51Z","timestamp":1536701871000},"page":"353-363","source":"Crossref","is-referenced-by-count":38,"title":["HLA-Mediated Platelet Refractoriness"],"prefix":"10.1093","volume":"151","author":[{"given":"Amy E","family":"Schmidt","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majed A","family":"Refaai","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myra","family":"Coppage","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,3]]},"reference":[{"key":"key\n\t\t\t\t2019030109210252500_CIT0001","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.bmt.1702490","article-title":"Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation","volume":"26","author":"Toor","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0002","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/1096-8652(200008)64:4<251::AID-AJH3>3.0.CO;2-N","article-title":"Platelet transfusions: utilization and associated costs in a tertiary care hospital","volume":"64","author":"Meehan","year":"2000","journal-title":"Am J Hematol"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0003","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1537-2995.2008.01799.x","article-title":"The clinical impact of platelet refractoriness: correlation with bleeding and survival","volume":"48","author":"Kerkhoffs","year":"2008","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0004","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2008.07189.x","article-title":"Platelet transfusion refractoriness","volume":"142","author":"Hod","year":"2008","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-3148.1993.tb00108.x","article-title":"Formulae for the definition of refractoriness to platelet transfusion","volume":"3","author":"Rebulla","year":"1993","journal-title":"Transfus Med"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0006","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1046\/j.1537-2995.1999.39060586.x","article-title":"Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution","volume":"39","author":"Davis","year":"1999","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0007","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bjh.13597","article-title":"Platelet refractoriness-practical approaches and ongoing dilemmas in patient management","volume":"171","author":"Stanworth","year":"2015","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0008","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.hoc.2016.01.008","article-title":"Management of the platelet refractory patient","volume":"30","author":"Forest","year":"2016","journal-title":"Hematol Oncol Clin North Am"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0009","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1423-0410.2011.01474.x","article-title":"Clinical relevance of the HLA system in blood transfusion","volume":"101","author":"Brown","year":"2011","journal-title":"Vox Sang"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0010","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1423-0410.2000.7920108.x","article-title":"HLA-C expression on platelets: studies with an HLA-Cw1-specific human monoclonal antibody","volume":"79","author":"Datema","year":"2000","journal-title":"Vox Sang"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0011","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1537-2995.2002.00051.x","article-title":"Platelet transfusion refractoriness caused by a mismatch in HLA-C antigens","volume":"42","author":"Saito","year":"2002","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0012","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3324\/haematol.2014.118075","article-title":"Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis","volume":"100","author":"Stanworth","year":"2015","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0013","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJM199712253372601","article-title":"Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions","volume":"337","author":"Trial to Reduce Alloimmunization to Platelets Study Group","year":"1997","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0014","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3389\/fimmu.2018.00880","article-title":"Emerging concepts in immune thrombocytopenia","volume":"9","author":"Swinkels","year":"2018","journal-title":"Front Immunol"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0015","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3389\/fimmu.2016.00570","article-title":"Detection of HLA antibodies in organ transplant recipients\u2014triumphs and challenges of the solid phase bead assay","volume":"7","author":"Tait","year":"2016","journal-title":"Front Immunol"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0016","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.humimm.2017.05.007","article-title":"Understanding solid-phase HLA antibody assays and the value of MFI","volume":"78","author":"Sullivan","year":"2017","journal-title":"Hum Immunol"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0017","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-6143.2009.02927.x","article-title":"Calculated PRA (CPRA): the new measure of sensitization for transplant candidates","volume":"10","author":"Cecka","year":"2010","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0018","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000351459","article-title":"Luminex(\u00ae) and its applications for solid organ transplantation, hematopoietic stem cell transplantation, and transfusion","volume":"40","author":"Lachmann","year":"2013","journal-title":"Transfus Med Hemother"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0019","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1097\/TP.0000000000001819","article-title":"Clinical utility of complement dependent assays in kidney transplantation","volume":"102","author":"Lan","year":"2018","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MOT.0b013e328355fb9b","article-title":"New approaches for detecting complement-fixing antibodies","volume":"17","author":"Tyan","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0021","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1016\/S0041-1345(99)00638-7","article-title":"Standardization of cellular immunoenzyme assay for anti-HLA class I antibodies evaluation: comparison with complement-dependent cytotoxicity methods","volume":"31","author":"Lieber","year":"1999","journal-title":"Transplant Proc"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0022","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood.V47.1.31.31","article-title":"Matching of histocompatibility (HL-A) antigens for platelet transfusion","volume":"47","author":"Mittal","year":"1976","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0023","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0198-8859(94)90270-4","article-title":"Epitope specificity of HLA class I alloantibodies, I: frequency analysis of antibodies to private versus public specificities in potential transplant recipients","volume":"39","author":"Rodey","year":"1994","journal-title":"Hum Immunol"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0024","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1182\/blood-2006-06-032193","article-title":"HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation","volume":"109","author":"Wade","year":"2007","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0025","first-page":"221","article-title":"Transfusion therapy of refractory thrombcytopenic patients with platelets from donors selectively mismatched for cross-reactive HLA antigens","volume":"9","author":"Duquesnay","year":"1977","journal-title":"Transplant Proc"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0026","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1182\/blood-2004-10-4080","article-title":"HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients","volume":"107","author":"Nambiar","year":"2006","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0027","doi-asserted-by":"crossref","first-page":"3406230","DOI":"10.1155\/2017\/3406230","article-title":"HLA epitopes: the targets of monoclonal and alloantibodies defined","volume":"2017","author":"El-Awar","year":"2017","journal-title":"J Immunol Res"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0028","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1182\/blood.V87.9.3959.bloodjournal8793959","article-title":"The effect of lymphocytotoxic antibody reactivity on the results of single antigen mismatched platelet transfusions to alloimmunized patients","volume":"87","author":"Hussein","year":"1996","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0029","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1182\/blood.V74.3.1172.1172","article-title":"Platelet transfusion therapy for alloimmunized patients: selective mismatching for HLA B12, an antigen with variable expression on platelets","volume":"74","author":"Schiffer","year":"1989","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0030","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1046\/j.1537-2995.2000.40121446.x","article-title":"Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity","volume":"40","author":"Petz","year":"2000","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0031","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1111\/j.1537-2995.2012.03593.x","article-title":"Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME)","volume":"52","author":"Wiita","year":"2012","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0032","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/tme.12423","article-title":"Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness","volume":"28","author":"Wang","year":"2018","journal-title":"Transfus Med"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0033","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/trf.12921","article-title":"Methods for the selection of platelet products for alloimmune-refractory patients","volume":"55","author":"Kopko","year":"2015","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0034","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1046\/j.1537-2995.1992.32792391036.x","article-title":"Selection of platelets for refractory patients by HLA matching and prospective crossmatching","volume":"32","author":"Moroff","year":"1992","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0035","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/j.1537-2995.2010.02703.x","article-title":"Epitope-based matching for HLA-alloimmunized platelet refractoriness in patients with hematologic diseases","volume":"50","author":"Pai","year":"2010","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0036","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1537-2995.2007.01516.x","article-title":"Structural epitope matching for HLA-alloimmunized thrombocytopenic patients: a new strategy to provide more effective platelet transfusion support","volume":"48","author":"Duquesnoy","year":"2008","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0037","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/j.1537-2995.2008.01837.x","article-title":"Validation of HLAMatchmaker algorithm in identifying acceptable HLA mismatches for thrombocytopenic patients refractory to platelet transfusions","volume":"48","author":"Brooks","year":"2008","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0038","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1182\/blood-2012-12-472779","article-title":"Low-level HLA antibodies do not predict platelet transfusion failure in TRAP study participants","volume":"121","author":"Jackman","year":"2013","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0039","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-0609.2011.01718.x","article-title":"Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP)","volume":"88","author":"Najaoui","year":"2012","journal-title":"Eur J Haematol"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0040","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/trf.13350","article-title":"Platelets made HLA deficient by acid treatment aggregate normally and escape destruction by complement and phagocytes in the presence of HLA antibodies","volume":"56","author":"Meinke","year":"2016","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0041","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.healun.2014.02.013","article-title":"Practical value of identifying antibodies to cryptic HLA epitopes in cardiac transplantation","volume":"33","author":"Oaks","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0042","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/TP.0b013e318186d87b","article-title":"\u201cNatural\u201d human leukocyte antigen antibodies found in nonalloimmunized healthy males","volume":"86","author":"Morales-Buenrostro","year":"2008","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0043","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/TP.0000000000000229","article-title":"Denatured class I human leukocyte antigen antibodies in sensitized kidney recipients: prevalence, relevance, and impact on organ allocation","volume":"98","author":"Visentin","year":"2014","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0044","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/TP.0b013e318199c581","article-title":"Detection of immunoglobulin G human leukocyte antigen-specific alloantibodies in renal transplant patients using single-antigen-beads is compromised by the presence of immunoglobulin M human leukocyte antigen-specific alloantibodies","volume":"87","author":"Kosmoliaptsis","year":"2009","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0045","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/01.tp.0000269615.91036.52","article-title":"The effect of antithymocyte globulin on anti-human leukocyte antigen antibody detection assays","volume":"84","author":"Gloor","year":"2007","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0046","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/TP.0000000000000315","article-title":"Deciphering complement interference in anti-human leukocyte antigen antibody detection with flow beads assays","volume":"98","author":"Visentin","year":"2014","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0047","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/TP.0b013e31822872dd","article-title":"HLA antibody specification using single-antigen beads-a technical solution for the prozone effect","volume":"92","author":"Schnaidt","year":"2011","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0048","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1097\/TP.0000000000001203","article-title":"Interpreting anti-HLA antibody testing data: a practical guide for physicians","volume":"100","author":"Schinstock","year":"2016","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0049","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.humimm.2009.04.001","article-title":"Naturally occurring interference in luminex assays for HLA-specific antibodies: characteristics and resolution","volume":"70","author":"Zachary","year":"2009","journal-title":"Hum Immunol"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0050","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/01.TP.0000441091.47464.c6","article-title":"Complement component C3 activation: the leading cause of the prozone phenomenon affecting HLA antibody detection on single-antigen beads","volume":"97","author":"Schwaiger","year":"2014","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0051","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1097\/TP.0000000000001270","article-title":"Technical limitations of the C1Q single-antigen bead assay to detect complement binding HLA-specific antibodies","volume":"101","author":"Taylor","year":"2017","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0052","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1111\/ajt.12462","article-title":"Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA-drilling down on key sources of variation","volume":"13","author":"Reed","year":"2013","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0053","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1111\/trf.12064","article-title":"Lot-to-lot variability in HLA antibody screening using a multiplexed bead-based assay","volume":"53","author":"Gandhi","year":"2013","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0054","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.humimm.2012.12.003","article-title":"Inter and intra laboratory concordance of HLA antibody results obtained by single antigen bead based assay","volume":"74","author":"Gandhi","year":"2013","journal-title":"Hum Immunol"},{"key":"key\n\t\t\t\t2019030109210252500_CIT0055","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/ajt.12807","article-title":"HLA antibody detection with solid phase assays: great expectations or expectations too great","volume":"14","author":"Gebel","year":"2014","journal-title":"Am J Transplant"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/151\/4\/353\/28001165\/aqy121.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T05:48:04Z","timestamp":1720590484000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/151\/4\/353\/5114639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,3]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,10,3]]},"published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqy121","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4]]},"published":{"date-parts":[[2018,10,3]]}}}